Contrary to other breast cancer (BC) subtypes, TNBC is characterized by the lack of expression of estrogen receptor (ER), progesterone receptor (PGR), and human epidermal growth factor receptor 2 (HER2) [1,2]. This evidence concerns the gene ERBB2 and breast carcinoma.